Bruno P Mmbando
Overview
Explore the profile of Bruno P Mmbando including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
78
Citations
1029
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Lyimo E, Kulaya N, Njotto L, Kassam N, Gesase S, Malabeja A, et al.
Malar J
. 2025 Mar;
24(1):68.
PMID: 40025559
Background: Malaria, which affects over half of the world's population, is controlled through clinical interventions and vector control strategies. However, these efforts are threatened by resistance to anti-malarial drugs and...
2.
Bhwana D, Amaral L, Kamoen O, Mhina A, Mushi V, Makunde W, et al.
Epilepsia
. 2024 Dec;
66(3):739-752.
PMID: 39698789
Objective: In onchocerciasis-endemic areas, limited access to antiseizure medications (ASMs) contributes to a high epilepsy burden. This study evaluated the impact of a community-based epilepsy care program in Mahenge, Tanzania,...
3.
Makani J, Masamu U, Tluway F, Sangeda R, Soka D, Osati E, et al.
EClinicalMedicine
. 2024 Oct;
76:102839.
PMID: 39431111
Background: Anaemia in sickle cell disease (SCD) is a significant cause of morbidity and mortality, but few studies have reported on the burden and outcome of very severe anaemia. This...
4.
Mushi V, Kidima W, Massawe I, Magili P, Bhwana D, Kaaya R, et al.
BMC Public Health
. 2024 Sep;
24(1):2608.
PMID: 39333993
Background: Epilepsy remains a significant public health concern in Tanzania, with affected individuals enduring stigma, whether through actions or perceptions. Myths, misunderstandings, and misconceptions about epilepsy have persisted due to...
5.
Mushi V, Bhwana D, Massawe I, Makunde W, Sebukoto H, Ngasa W, et al.
PLoS Negl Trop Dis
. 2024 Sep;
18(9):e0012470.
PMID: 39241094
Introduction: Epidemiological evidence suggests that Onchocerca volvulus is associated with epilepsy, although the exact pathophysiological mechanism is unknown. Mahenge is an endemic focus of onchocerciasis, with the longest-running ivermectin treatment...
6.
Sasi P, Makubi A, Sangeda R, Ngaeje M, Mmbando B, Soka J, et al.
Commun Med (Lond)
. 2024 Aug;
4(1):160.
PMID: 39122788
Background: Sickle cell anemia (SCA) prevalence remains high in sub-Saharan Africa. Long-term treatment with hydroxyurea (HU) increases survival, however, poor adherence to treatment could limit effectiveness. Whilst HU treatment adherence...
7.
Colebunders R, Hadermann A, Njamnshi A, Mmbando B, Kamoen O, Fodjo J
PLoS Negl Trop Dis
. 2024 May;
18(5):e0011808.
PMID: 38722830
No abstract available.
8.
Ngasala B, Chiduo M, Mmbando B, Francis F, Bushukatale S, Makene T, et al.
Malar J
. 2024 Apr;
23(1):101.
PMID: 38594679
Background: Artemisinin-based combination therapy (ACT) has been a major contributor to the substantial reductions in global malaria morbidity and mortality over the last decade. In Tanzania, artemether-lumefantrine (AL) was introduced...
9.
Ngasala B, Chiduo M, Bushukatale S, Mmbando B, Makene T, Kamugisha E, et al.
Malar J
. 2024 Apr;
23(1):95.
PMID: 38582830
Background: The use of artemisinin-based combination therapy (ACT) is recommended by the World Health Organization for the treatment of uncomplicated falciparum malaria. Artemether-lumefantrine (AL) is the most widely adopted first-line...
10.
Mwaiswelo R, Ngasala B, Chaky F, Molteni F, Mohamed A, Lazaro S, et al.
Sci Rep
. 2024 Jan;
14(1):2143.
PMID: 38273019
Effectiveness of dihydroartemisinin-piperaquine (DP) as seasonal malaria chemoprevention (SMC) was assessed in Nanyumbu and Masasi Districts. Between March and June 2021, children aged 3-59 months were enrolled in a cluster...